EP4229046A1 - Dérivés de 4,6-difluorodibenzothiophène et milieu de cristaux liquides les contenant - Google Patents
Dérivés de 4,6-difluorodibenzothiophène et milieu de cristaux liquides les contenantInfo
- Publication number
- EP4229046A1 EP4229046A1 EP21790221.2A EP21790221A EP4229046A1 EP 4229046 A1 EP4229046 A1 EP 4229046A1 EP 21790221 A EP21790221 A EP 21790221A EP 4229046 A1 EP4229046 A1 EP 4229046A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- atoms
- compounds
- liquid
- alkyl
- denote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 81
- YMEOPMLPGHEHOB-UHFFFAOYSA-N FC1=CC=CC2=C1SC1=C2C=CC=C1F Chemical class FC1=CC=CC2=C1SC1=C2C=CC=C1F YMEOPMLPGHEHOB-UHFFFAOYSA-N 0.000 title abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 227
- 125000004432 carbon atom Chemical group C* 0.000 claims description 111
- 125000000217 alkyl group Chemical group 0.000 claims description 93
- 125000003342 alkenyl group Chemical group 0.000 claims description 48
- 229910052731 fluorine Inorganic materials 0.000 claims description 39
- 125000003545 alkoxy group Chemical group 0.000 claims description 33
- 229910052801 chlorine Inorganic materials 0.000 claims description 30
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 13
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 6
- 150000001350 alkyl halides Chemical class 0.000 claims description 3
- -1 alkoxy radical Chemical class 0.000 description 74
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 50
- 239000000460 chlorine Substances 0.000 description 35
- 239000000203 mixture Substances 0.000 description 35
- 150000003254 radicals Chemical class 0.000 description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 230000004044 response Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 239000002019 doping agent Substances 0.000 description 8
- 229910052698 phosphorus Inorganic materials 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 238000002834 transmittance Methods 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000004642 Polyimide Substances 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 3
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- XZKFBZOAIGFZSU-UHFFFAOYSA-N 1-bromo-4-methylpentane Chemical compound CC(C)CCCBr XZKFBZOAIGFZSU-UHFFFAOYSA-N 0.000 description 2
- SZTBMYHIYNGYIA-UHFFFAOYSA-M 2-chloroacrylate Chemical compound [O-]C(=O)C(Cl)=C SZTBMYHIYNGYIA-UHFFFAOYSA-M 0.000 description 2
- WWQRDAMGSQVYAE-UHFFFAOYSA-N 2-ethenoxyprop-2-enoic acid Chemical compound OC(=O)C(=C)OC=C WWQRDAMGSQVYAE-UHFFFAOYSA-N 0.000 description 2
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 239000004988 Nematic liquid crystal Substances 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- ZYMKZMDQUPCXRP-UHFFFAOYSA-N fluoro prop-2-enoate Chemical compound FOC(=O)C=C ZYMKZMDQUPCXRP-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XKVLZBNEPALHIO-YFKPBYRVSA-N (2s)-1-bromo-2-methylbutane Chemical compound CC[C@H](C)CBr XKVLZBNEPALHIO-YFKPBYRVSA-N 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 1
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- OVOVDHYEOQJKMD-UHFFFAOYSA-N 2,4-dimethylpentan-1-ol Chemical compound CC(C)CC(C)CO OVOVDHYEOQJKMD-UHFFFAOYSA-N 0.000 description 1
- 125000003764 2,4-dimethylpentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004337 3-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 101150026303 HEX1 gene Proteins 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- WZXXNQCYYKTIBW-UHFFFAOYSA-N Oc1ccc2c3ccc(O)c(F)c3sc2c1F Chemical compound Oc1ccc2c3ccc(O)c(F)c3sc2c1F WZXXNQCYYKTIBW-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000005569 butenylene group Chemical group 0.000 description 1
- FGNLEIGUMSBZQP-UHFFFAOYSA-N cadaverine dihydrochloride Chemical compound Cl.Cl.NCCCCCN FGNLEIGUMSBZQP-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000002288 cocrystallisation Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000005725 cyclohexenylene group Chemical group 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 101150047356 dec-1 gene Proteins 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- RBBNOVKRLWDEGC-UHFFFAOYSA-M dodecyl-ethyl-dimethylazanium;4-hexoxybenzoate Chemical compound CCCCCCOC1=CC=C(C([O-])=O)C=C1.CCCCCCCCCCCC[N+](C)(C)CC RBBNOVKRLWDEGC-UHFFFAOYSA-M 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005446 heptyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 125000006238 prop-1-en-1-yl group Chemical group [H]\C(*)=C(/[H])C([H])([H])[H] 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 125000005407 trans-1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])[C@]([H])([*:2])C([H])([H])C([H])([H])[C@@]1([H])[*:1] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K2019/0444—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
- C09K2019/0466—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the linking chain being a -CF2O- chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/12—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
- C09K2019/121—Compounds containing phenylene-1,4-diyl (-Ph-)
- C09K2019/122—Ph-Ph
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/30—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
- C09K19/3001—Cyclohexane rings
- C09K19/3003—Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
- C09K2019/3004—Cy-Cy
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/30—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
- C09K19/3001—Cyclohexane rings
- C09K19/3003—Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
- C09K2019/301—Cy-Cy-Ph
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/30—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
- C09K19/3001—Cyclohexane rings
- C09K19/3003—Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
- C09K2019/3025—Cy-Ph-Ph-Ph
Definitions
- the present invention relates to 4,6-difluorodibenzothiophene derivatives, to a process for the preparation thereof, to liquid-crystalline (LC) media comprising these derivatives, and to electro-optical devices and in particular displays containing these liquid-crystalline media.
- LC liquid-crystalline
- Liquid crystals have found widespread use since the first commercially usable liquid-crystalline compounds were found.
- Liquid-crystal displays are used in many areas for the display of information. LCDs are used both for direct-view displays and for projection-type displays.
- the spatial arrangement of the molecules in a liquid crystal has the effect that many of its properties are direction-dependent.
- the optical, dielectric and elasto-mechanical anisotropies are the optical, dielectric and elasto-mechanical anisotropies.
- the dielectric constant s of the liquid-crystalline medium has different values for the two orientations.
- Substances whose dielectric constant is larger when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are known as being dielectrically positive. Substances whose dielectric constant is smaller when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are known as being dielectrically negative.
- the dipole moment oriented along the longitudinal axis of the molecules is larger than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.
- a liquid-crystalline layer with a thickness of only from about 5 to 10 pm is arranged between two flat glass plates, onto each of which an electrically conductive, transparent layer of tin oxide or indium tin oxide has been vapour-deposited as electrode.
- This alignment layer serves to bring the longitudinal axes of the adjacent crystalline molecules into a preferential direction through surface forces in such a way that, in the voltage-free state, they lie uniformly on the inside of the display surface with the same alignment in a flat manner or with the same small tilt angle.
- Two polarisation films which only enable linear-polarised light to enter and escape are adhesively bonded to the outside of the display in a certain arrangement.
- liquid crystals in which the larger dipole moment is oriented parallel to the longitudinal axis of the molecule, very high-performance displays have already been developed. In most cases, mixtures of from 5 to 20 components are used in order to achieve a sufficiently broad temperature range of the mesophase and short response times and low threshold voltages.
- difficulties are still caused by the strong viewing-angle dependence in liquid-crystal displays as used, for example, for laptops.
- the best imaging quality can be achieved if the surface of the display is perpendicular to the viewing direction of the observer. If the display is tilted relative to the observation direction, the imaging quality drops drastically under certain circumstances.
- WO 91/10936 describes a liquid-crystal display in which the electric signals are generated in such a way that the electric fields have a significant component parallel to the liquid-crystal layer, and which has since then become known as in-jolane switching (IPS) display.
- IPS in-jolane switching
- IPS displays contain an LC layer between two substrates with planar orientation, where the two electrodes are arranged on only one of the two substrates and preferably have interdigitated, comb-shaped structures. On application of a voltage to the electrodes an electric field with a significant component parallel to the LC layer is generated between them. This causes realignment of the LC molecules in the layer plane.
- FFS field switching
- FFS displays have a low viewing-angle dependence of the contrast.
- FFS displays usually contain an LC medium with positive dielectric anisotropy and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium.
- Liquid-crystal displays of the IPS and FFS electro-optical mode are in particular suitable for use in modem desktop monitors, TV sets and multimedia applications.
- the liquid-crystalline media according to the present invention are preferably used in displays of this type.
- dielectrically positive liquid-crystalline media having rather lower values of the dielectric anisotropy are used in FFS displays, but in some cases liquidcrystalline media having a dielectric anisotropy of only about 3 or even less are also used in IPS displays.
- HB-FFS mode A further improvement has been achieved by the so-called HB-FFS mode.
- One of the unique features of the HB-FFS mode in contrast to the traditional FFS technology is that it enables higher transmittance which allows operation of the panel with less energy consumption.
- Liquid-crystal compositions which are suitable for LCDs and especially for FFS and IPS displays are known from, for example, JP 07-181 439 (A), EP 0 667 555, EP 0 673 986, DE 195 09 410, DE 195 28 106, DE 19528 107, WO 96/23 851 and WO 96/28 521.
- these compositions have certain disadvantages. Amongst other deficiencies, most of them result in disadvantageously long addressing times, have inadequate values of the resistivity and/or require excessively high operating voltages. Both an improvement in the operating properties and also in the shelf life are desirable.
- IPS in-plane switching
- FFS fringe-field switching
- Both the IPS and the FFS technology have certain advantages over other LCD technologies, such as, for example, the vertical alignment (VA) technology, e.g. a broad viewing angle dependency of the contrast.
- VA vertical alignment
- WO 02/055463 A1 and EP 2 937 342 A1 describe fluorinated aromatic compounds and their use in liquid crystal mixtures and the use of the mixtures in liquid crystal displays.
- An object of the present invention is therefore to provide compounds, in particular mesogenic compounds, which have favourable properties for use in liquid-crystalline mixtures and which can give benefits in these mixtures which are suitably advantageous to further optimise the liquid crystal materials and displays. It is also an object to provide a facile process to prepare these compounds.
- liquid-crystalline media in particular for FFS, HB-FFS and IPS displays, but also for TN, positive VA or STN displays, and in particular for active-matrix displays like those addressed by TFTs, which do not exhibit the disadvantages indicated above or only do so to a lesser extent and which preferably have high specific resistance, low threshold voltage, suitable dielectric anisotropy, a good low temperature stability (LTS), fast response times and low rotation
- the present invention in particular provides the following items including main aspects, preferred embodiments and particular features, which respectively alone and in combination contribute to solving the above object and eventually provide additional advantages.
- a first aspect of the present invention provides a compound selected from the group of compounds of formulae 1-1 and I-2 in which
- R 11 denotes H, an alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH 2 groups in these radicals are optionally replaced, independently of one another, by
- R 12 denotes a branched alkyl or alkoxy radical having 1 to 15 C atoms.
- the compounds according to the invention can exhibit favourable solubility in liquid-crystalline media and in addition can favourably contribute to the stability and reliability of the media
- these compounds are in particular useful to set and adjust or tune the electro-optical properties of liquid-crystalline media, which in turn can be useful to further optimise LC displays.
- these compounds can be included in liquidcrystalline media having overall a positive dielectric anisotropy. This provision can be useful to increase the dielectric constant s ⁇ perpendicular to the longitudinal axes of the liquid-crystalline molecules and be beneficial e.g. in terms of increasing the transmission in certain display modes as further described below.
- Another aspect of the invention relates to a liquid-crystal medium which comprises one or more compounds selected from the group of compounds of formulae 1-1 and I-2 as set forth herein.
- the liquid-crystal medium has a positive dielectric anisotropy, in particular a dielectric anisotropy of +0.5 or more.
- a high brightness in displays like those of the HB-FFS mode can be obtained by using liquid-crystalline media having positive dielectric anisotropy and also having an increased dielectric constant s ⁇ perpendicular to the longitudinal axes of the liquidcrystalline molecules.
- This provision can advantageously be achieved by adding a limited amount of the one or more liquid-crystalline compounds according to the invention, which have a negative dielectric anisotropy and which have high s ⁇ properties, to the liquid-crystalline medium whilst maintaining a positive dielectric anisotropy of the entire medium.
- the media comprising the compound(s) according to the invention advantageously show a relatively high value of s ⁇ and at the same time enable a decrease of the rotational viscosity and the ratios of yi /K22 and yi /Ku, and enable fast response times in displays using liquidcrystalline media as described and claimed herein.
- the displays that make use of the media according to the invention favourably exhibit a particularly high contrast and suitable reliability.
- liquid-crystalline media which show a moderately positive dielectric anisotropy and at the same time an increased dielectric constant s ⁇ perpendicular to the longitudinal axes of the liquid-crystalline molecules may be provided, which favourably can maintain a low rotational viscosity and a low value of the ratio yi /Ku.
- liquidcrystal displays especially of the HB-FFS, FFS and IPS modes, with high brightness and transmittance and short response times.
- liquid-crystalline media according to the invention are suitable for mobile applications and TFT applications, such as, for example, mobile telephones and PDAs. Furthermore, the liquid-crystalline media according to the invention are particularly suitable for use in FFS, HB-FFS and IPS displays based on dielectrically positive liquid crystals.
- liquid-crystal media according to the present invention are especially suitable for use in liquid-crystal displays of the FFS, HB-FFS and IPS modes, based on dielectrically positive liquid crystals, and polymer stabilised variants thereof, in particular for large size TV applications.
- a further aspect of the invention relates to electro-optical devices containing the liquid-crystal medium according to the invention and in particular to a liquid-crystal display.
- the electro-optical device is a TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, PS-HB-FFS, SA-HB-FFS, polymer stabilised SA-HB-FFS, positive VA or positive PS-VA display.
- the process comprises the step of subjecting a branched haloalkane to a chemical reaction.
- the branched haloalkane preferably is a branched bromoalkane.
- halogen denotes F, Cl, Br or I, preferably F or Cl, and more preferably F.
- all atoms also include their isotopes.
- one or more hydrogen atoms (H) may be replaced by deuterium (D), which is particularly preferred in some embodiments; a high degree of deuteration enables or simplifies analytical determination of compounds, in particular in the case of low concentrations.
- an alkyl radical and/or an alkoxy radical is taken to mean straightchain or branched alkyl or respectively alkoxy. It is preferably straight-chain, has 2, 3, 4, 5, 6 or 7 C atoms and accordingly preferably denotes ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexyloxy or heptyloxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy or tetradecyloxy.
- alkenyl may be straight-chain or branched. It is preferably straight-chain and has 2 to 10 C atoms. Accordingly, it denotes, in particular, vinyl, prop-1- or -2-enyl, but-1 -, -2- or -3-enyl, pent-1 -, -2-, -3- or -4-enyl, hex-1 -, -2-, -3-, -4- or -5-enyl, hept-1 -, -2-, -3-, -4-, -5- or -6-enyl, oct-1-, -2-, -3-, -4-, -5-, -6- or -7-enyl, non-1 -, -2-, -3-, -4-, -5-, -6-, -7- or -8-enyl, dec-1
- an alkyl or alkenyl radical which is at least monosubstituted by halogen is preferably straight-chain, and halogen is preferably F or Cl.
- halogen is preferably F.
- the resultant radicals also include perfluorinated radicals.
- the fluorine or chlorine substituent may be in any desired position, but is preferably in the o-position.
- 1 ,4-cyclohexylene rings are depicted as follows: wherein the cyclohexylene rings are trans-1 ,4-cyclohexylene rings.
- the compound according to the invention is selected from the group of compounds of formulae 1-1 and I-2 as set forth herein.
- composition or mixture which comprises, preferably consists of, two or more compounds selected from the group of compounds of formulae 1-1 and I-2.
- the compound according to the invention is selected from the compounds of formula 1-1 .
- the compound according to the invention is selected from the compounds of formula I-2.
- R 12 in formulae 1-1 and I-2 denotes a branched alkyl or alkoxy radical having 1 to 15 C atoms.
- the branched alkyl moiety of these groups may be selected from secondary and/or tertiary alkyl, preferably from secondary alkyl.
- the groups R 11 and R 12 in formula 1-1 and/or formula I-2 denote, independently of each other, branched alkyl or alkoxy radicals having 1 to 15 C atoms, preferably branched alkoxy radicals having 1 to 15 C atoms.
- the group R 11 in formula 1-1 and/or formula I-2 denotes an unbranched, i.e. straight-chain alkyl or alkoxy radical having 1 to 9 C atoms, preferably a straight-chain alkoxy radical having 1 to 9 C atoms. It is particularly preferred that R 11 denotes a straight-chain alkoxy radical having 1 to 7 C atoms.
- the group R 12 in formula 1-1 and/or formula I-2 denotes a branched alkyl or alkoxy radical having 1 to 12 C atoms, preferably a branched alkoxy radical having 1 to 12 C atoms.
- Branched alkoxy groups for R 12 in formula 1-1 and/or formula I-2 are preferably selected from isopropoxy, isobutoxy, isopentoxy, isohexyloxy, isoheptyloxy, isooctyloxy, isononyloxy, 1 -methyl propoxy, 2-methylbutoxy, 3- methylpentoxy, 4-methylhexyloxy, 2-ethylbutoxy, 3-ethylpentoxy, 2,4- dimethylpentoxy and 3,4-dimethylhexyloxy, more preferably from isobutoxy, isopentoxy, isohexyloxy, isoheptyloxy, 2-methylbutoxy and 2,4- dimethylpentoxy, and particularly preferably from isobutoxy and isopentoxy.
- R 12 groups in formula 1-1 and/or formula I-2 are branched alkyl groups which are preferably selected from isopropyl, isobutyl, isopentyl, isohexyl, isoheptyl, isooctyl, isononyl, 1 -methylpropyl, 2- methylbutyl, 3-methylpentyl, 4-methylhexyl, 2-ethylbutyl, 3-ethyl-pentyl, 2,4- dimethylpentyl, 3,4-dimethylhexyl, more preferably from isobutyl, isopentyl and isohexyl.
- the compound according to the present invention is selected from the group of compounds of formulae l-A to l-N
- the compounds of the formulae 1-1 and I-2 can be synthesised by methods known per se, as are described in the literature, e.g. in the standard works such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart, and specifically under reaction conditions which are known and suitable for the specified reactions. In this connection, it is also possible to utilise variants known per se that are not mentioned here in more detail.
- the starting materials may optionally also be formed in situ such that they are not isolated from the reaction mixture but are immediately reacted further to give the compounds of formula 1-1 and/or formula I-2.
- Preferred synthetic pathways towards compounds according to the invention are shown in the scheme below and are further illustrated by means of the Working Examples.
- the syntheses can be adapted to the particular desired compounds of the formulae 1-1 and I-2 by choice of suitable starting materials.
- Preferred compounds of formulae 1-1 and I-2 are preferably synthesized as shown in Scheme 1 .
- the described process steps and the subsequent work-up of the reaction mixture can in principle be carried out as a batch reaction or in a continuous reaction mode.
- the continuous reaction mode involves e.g. the reaction in a continuous stirred-tank reactor, a stirred-tank cascade, a loop or crossflow reactor, a flow tube or in a microreactor.
- the work-up of the reaction mixtures is optionally carried out, as required, by filtration through solid phases, chromatography, separation between immiscible phases, e.g. extraction, adsorption onto solid supports, disti Native removal of solvents and/or azeotropic mixtures, selective distillation, sublimation, crystallisation, co-crystallisation or by nanofiltration through membranes.
- the present invention relates to a process for the preparation of compounds of the formulae 1-1 and I-2, in particular in accordance with the syntheses shown above.
- the compound selected from the group of compounds of formulae 1-1 and I-2 as set forth herein is used in a liquid-crystalline medium.
- liquid-crystal medium comprises two or more compounds selected from the group of the compounds of the formulae 1-1 and I-2.
- the liquid-crystalline medium is a liquid-crystalline mixture which besides the one or more compounds according to the invention comprises one or more mesogenic compounds which are different from the former compounds.
- liquid-crystal medium according to the invention includes at least one compound of formula 1-1.
- liquid-crystal medium according to the invention includes at least one compound of formula I-2.
- liquid-crystal medium according to the invention includes at least one compound of formula 1-1 and in addition at least one compound of formula I-2.
- the one or more compounds selected from the group of compounds of formulae 1-1 and I-2 and in particular the further preferred compounds thereof are contained in the liquid-crystal medium in a total amount of 20% by weight or less, more preferably 15% by weight or less and even more preferably 10% by weight or less. It is preferred that the total amount of the one or more compounds selected from the group of compounds of formulae 1-1 and I-2 and in particular the further preferred compounds thereof contained in the liquid-crystal medium is in the range of from 2.5% by weight to 20% by weight, more preferably from 5% by weight to 15% by weight and in particular from 7% by weight to 10% by weight.
- the liquid-crystal medium has a positive dielectric anisotropy As.
- the dielectric anisotropy As is preferably determined at 20°C and 1 kHz.
- the liquid-crystal medium preferably has a dielectric anisotropy As of +0.5 or more, more preferably of +1 .5 or more, and even more preferably of +2.5 or more. It is particularly preferred that the liquid-crystal medium exhibits a dielectric anisotropy As in the range of from +1 .5 to +12.0, more preferably from +3.0 to +10.0, even more preferably from +4.0 to +8.0 and in particular from +4.5 to +6.0.
- liquid-crystal medium further comprises one or more compounds selected from the group of compounds of formulae 11-1 and II-2
- R 2 denotes alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, or alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, in which optionally one or more CH 2 groups, independently of one another, may be replaced by are independently of each other
- L 25 denotes H or CH 3 .
- X 2 denotes halogen, preferably F, halogenated alkyl or alkoxy with 1 to 3 C atoms or halogenated alkenyl or alkenyloxy with 2 or 3 C atoms.
- the medium preferably comprises the one or more compounds of formulae 11-1 and/or 11-2 in a total amount of 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, still more preferably 20% by weight or more and in particular 22.5% by weight or more.
- L 21 and L 22 or L 23 and L 24 are preferably both F.
- the compounds of formula 11-1 are preferably selected from compounds of formula 11-1 -a in which the the occurring groups have the meanings given in for formula II- 1 , and wherein preferably X 2 is F.
- the medium comprises one or more compounds of formula 11-1 -a-1
- the one or more compounds of formula 11-1 -a-1 are preferably contained in the liquid-crystal medium in a total amount of 5% by weight or more, more preferably 10% by weight or more and in particular in a range of from 15% by weight to 20% by weight.
- liquid-crystal medium comprises one or more compounds selected from the compounds of formulae 11-1 -b to 11-1 -h
- R 2 has the meaning as given in formula 11-1 .
- the compounds of formula II-2 are preferably selected from the group of compounds of formulae ll-2-a, ll-2-b, ll-2-c and ll-2-d
- the medium comprises compounds selected from the group of compounds of formulae ll-2-a to ll-2-d, wherein L 21 and L 22 or L 23 and L 24 are both F.
- the medium comprises compounds selected from the group of compounds of formulae ll-2-a to ll-2-d, wherein L 21 [_22
- are p
- the medium comprises one or more compounds selected from the of compounds of formula ll-2-d.
- Especially preferred compounds of formula II-2 are compounds of formulae ll-2-i, ll-2-ii, ll-2-iii and ll-2-iv
- R 2 has the meaning given for formula II-2 above.
- the medium contains at least one compound of formula ll-2-i, preferably in a total amount of 2.5% by weight or more, more preferably 3.5% by weight or more and in particular 4.5% by weight or more.
- liquid-crystal medium comprises one or more compounds selected from the compounds of formulae II-2-A to II-2-L
- R 2 has the meaning given for formula 11-2 above.
- liquid-crystal medium comprises one or more compounds selected from the group of compounds of formulae 111-1 to HI-32
- R 3 has the meaning as given for R 2 in formula 11-2 above.
- the liquid-crystal medium preferably comprises at least one compound of formula 111-1 , preferably in an amount of at least 2% by weight, more preferably at least 5% by weight.
- the medium according to the invention comprises one or more compounds of formula IV in which
- the liquid-crystal media according to the present invention comprise one or more compounds of formula IV selected from the group of compounds of formulae IV-1 to IV-5 in which R 41 and R 42 have the respective meanings given under formula IV above and in formulae IV-1 , IV-4 and IV-5
- R 41 preferably is alkyl or alkenyl, preferably alkenyl and R 42 preferably is alkyl or alkenyl, preferably alkyl
- R 41 and R 42 preferably are alkyl and in formula IV-3
- R 41 preferably is alkyl or alkenyl, preferably alkyl and R 42 preferably is alkyl or alkoxy, preferably alkoxy.
- the medium according to the invention comprises one or more compounds of formula IV-1 and one or more compounds of formula IV-4.
- the medium further comprises one or more compounds of formula IV selected from the group of compounds of formulae IV-6 to IV-13
- R 41 and R 42 independently of each other, denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, and
- L 4 denotes H or F.
- the medium comprises one or more compounds of formula IV-1 in which
- R 41 and R 42 independently of each other, denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, or alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms.
- the liquid-crystal medium comprises the one or more compounds of formula I V-1 in a total amount of at least 10% by weight, more preferably at least 20% by weight, even more preferably at least 30% by weight and in particular at least 34% by weight.
- liquid-crystal medium comprises one or more compounds of formula IV-13, in which L 4 is F.
- the media may comprise one or more compounds of formula V in which
- R 5 is alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with
- alkenyl 1 to 7 C atoms, alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, and preferably is alkyl with 1 to 7 C atoms or alkenyl with 2 to 7 C atoms,
- L 51 and L 52 independently of each other, denote H or F, preferably L 51 denotes F,
- X 5 denotes halogen, halogenated alkyl or alkoxy with 1 to 3
- the media according to the present invention comprise one or more compounds of formula V selected from the group of compounds of formulae V-1 and V-2 in which the parameters have the respective meanings given for formula V above, and the parameters L 53 and L 54 are, independently of each other, H or F, and preferably Z 5 is -CH 2 -CH 2 -.
- the compounds of formula V-1 are selected from the group of compounds of formulae V-1 a and V-1 b in which the R 5 has the meaning given for formula V above.
- the compounds of formula V-2 are selected from the group of compounds of formulae V-2a to V-2d in which the R 5 has the meaning given for formula V above.
- liquid-crystalline media according to the present invention additionally comprise one or more compounds of formula VI in which
- R 61 and R 62 independently of each other, denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, or alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, preferably R 61 is alkyl and R 62 is alkyl or alkenyl, each having up to 7 C atoms,
- the liquid-crystal medium comprises one or more compounds of formula VI-1 , preferably in a total amount of at least 2.5% by weight, more preferably at least 4% by weight, and in particular at least 7.5% by weight.
- the medium according to the invention comprises one or more compounds of formula Y in which the individual radicals have the following meaning:
- L 1 , L 2 , L 3 and L 4 independently of each other, denote H, F or Cl, preferably H or F, more preferably F, and x, y independently of each other, denote 0, 1 or 2, with x+y ⁇ 3.
- the compounds of formula Y contain at least one substituent L 1-4 that is F or Cl, preferably F, more preferably at least two substituents L 1-4 that are F.
- R 1 and R 2 preferably denote straight-chain alkyl or alkoxy having 1 to 6 C atoms, furthermore alkenyl having 2 to 6 C atoms, in particular vinyl, 1 E-propenyl, 1 E-butenyl, 3-butenyl, 1 E-pentenyl, 3E-pentenyl or 4-pentenyl.
- both radicals L 1 and L 2 denote F.
- one of the radicals L 1 and L 2 denotes F and the other denotes Cl.
- the medium contains one or more compounds of formula Y that are selected from the following subformulae in which R 1 , R 2 , Z x , Z y , L 1 and L 2 have one of the meanings given in formula
- a denotes 1 or 2
- b denotes 0, 1 or 2, preferably 1 or 2
- L 3 , L 4 independently of each other, denote F or Cl, preferably F.
- both L 1 and L 2 denote F or one of L 1 and L 2 denotes F and the other denotes Cl
- both L 3 and L 4 denote F or one of L 3 and L 4 denotes F and the other denotes Cl.
- the medium comprises one or more compounds of the formula Y1 selected from the group consisting of the following subformulae
- alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
- alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms
- (0) denotes an oxygen atom or a single bond.
- the medium contains one or more compounds of formula
- Y1 selected from formulae Y1-2 and Y1-10.
- the medium comprises one or more compounds of the formula Y2 selected from the group consisting of the following subformulae:
- alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
- alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms
- (0) denotes an oxygen atom or a single bond.
- the medium contains one or more compounds of formula Y2 selected from formulae Y2-2 and Y2-10, in particular one or more compounds of formula Y2-10.
- the proportion of the compounds of formula Y1 or its subformulae in the medium is preferably from 1 to 10% by weight.
- the proportion of the compounds of formula Y2 or its subformulae, in particular formula Y2-10, in the medium is preferably from 1 % by weight to 15% by weight, more preferably from 2% by weight to 10% by weight.
- the total proportion of the compounds of formulae Y1 and Y2 or their subformulae in the medium is preferably from 0 to 20%, very preferably from 1 to 15%, most preferably from 1 to 10% by weight.
- the medium contains 1 , 2 or 3 compounds of formulae Y1 and Y2 or their subformulae, very preferably selected from formulae Y1 -2, Y1 -10, Y2-2 and Y2-10.
- the medium comprises one or more compounds of formula Y selected from the following subformula in which R 1 , R 2 , L 1 , L 2 , X, x and Z x have the meanings given in formula Y, in which at least one of the rings X is cyclohexenylene. If x is 2, preferably, one ring X is cyclohexylene-1 ,4-diyl and the other ring X is cyclohexylene-1 ,4-diyl or cyclohexane-1 ,4-diyl.
- LY x is 1 or 2
- both radicals L 1 and L 2 denote F.
- one of the radicals L 1 and L 2 denotes F and the other denotes Cl.
- the compounds of the formula LY are preferably selected from the group consisting of the following sub-formulae: in which R 1 has the meaning indicated for formula LY above, (O) denotes an oxygen atom or a single bond, and v denotes an integer from 1 to 6.
- the medium contains 1, 2 or 3 compounds of formula LY.
- the proportion of the compounds of formula LY or its subformulae in the medium is preferably from 0 to 15% by weight. It is particularly preferred that the medium contains one or more compounds of formula LY4, wherein the proportion of the compounds of formula LY4 in the medium preferably is from 1 % by weight to 15% by weight, more preferably from 2% by weight to 10% by weight.
- the medium comprises one or more compounds selected from the group of compounds of formulae Y4-1 to Y4-24
- R denotes a straight-chain alkyl or alkoxy radical having 1 to 7 C atoms
- R* denotes a straight-chain alkenyl radical having 2 to 7 C atoms
- (0) denotes an oxygen atom or a single bond
- m denotes an integer from 1 to 6.
- R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy or pentoxy.
- the total proportion of the compounds of formulae 1-1 , I-2 and Y, and in particular their respective sub-formuale, in the medium is from 2% by weight to 30% by weight, more preferably from 5% by weight to 26% by weight, and even more preferably from 8% by weight to 20% by weight.
- liquid-crystal medium further comprises one or more compounds selected from the group of compounds of formulae B-1 , B-2 and B-3
- the compounds of formula B-1 are preferably selected from the group of compounds of the formulae B-1 -a to B-1 -e
- R 11 and R 12 denote alkyl having 1 to 7 C atoms, preferably ethyl, n-propyl, n-butyl or n-pentyl.
- the compounds of formula B-2 are preferably selected from the group of compounds of the formulae B-2-a to B-2-e
- R 11 and R 12 identically or differently, denote alkyl having 1 to 12 C atoms, preferably alkyl having 1 to 7 C atoms.
- the compounds of formula B-3 are preferably selected from the group of compounds of the formulae B-3-a to B-3-j in which R 12 denotes alkyl having 1 to 7 C atoms, preferably ethyl, n-propyl or n-butyl.
- the one or more compounds selected from the group of compounds of formulae B-1 , B-2 and B-3 are selected from the group of compounds B-A to B-J
- the one or more compounds selected from the group of compounds of formulae B-1 , B-2 and B-3 are preferably comprised in the liquid-crystal medium in a total amount of from 0 to 15% by weight, more preferably 10% by weight or less and even more preferably 5% by weight or less.
- the liquid-crystal media according to the invention preferably retain the nematic phase down to -20°C, more preferably down to -30°C, and even more preferably down to -40°C.
- the liquid-crystal media according to the invention have a clearing point of > 75°C, more preferably
- liquid-crystal media preferably exhibit rotational viscosities yi of ⁇ 110 mPa-s, particularly preferably ⁇ 100 mPa-s, where the rotational viscosities are determined at 20°C.
- rotational viscosities yi of ⁇ 110 mPa-s, particularly preferably ⁇ 100 mPa-s, where the rotational viscosities are determined at 20°C.
- the liquid-crystal medium preferably has an optical anisotropy An of 0.06 or more, more preferably 0.08 or more, still more preferably 0.10 or more and even more preferably 0.12 or more.
- the liquid-crystal medium preferably has an optical anisotropy in the range of from 0.07 to 0.15 and in particular from 0.10 to 0.12.
- the rotational viscosity yi of the liquid-crystal media preferably is ⁇ 80 mPa s, more preferably ⁇ 70 mPa s, and even more preferably ⁇ 60 mPa s.
- the ratio yi/Kn, in which yi is the rotational viscosity and Ku is the elastic constant for splay deformation, of the liquid-crystal media preferably is ⁇ 4.5 mPa-s/pN, more preferably ⁇ 4.2 mPa-s/pN, most preferably ⁇ 4.0 mPa-s/pN.
- the nematic phase range of the liquid-crystal media according to the invention preferably has a width of at least 90°C, more preferably of at least 100°C, in particular of at least 110°C. This range particularly preferably extends at least from -25°C to +80°C.
- liquid-crystal medium can favourably contribute to obtaining an advantageous electro- optical device performance, e.g. in terms of the achievable contrast and the high bright state transmittance, while exhibiting functionality and reliability also at high temperatures and at low temperatures.
- the medium according to the invention comprises
- one or more compounds of formula 11-1 -a-1 preferably in a total amount of 5% by weight or more, more preferably 10% by weight or more and in particular in a range of from 15% by weight to 20% by weight, and/or - at least one compound of formula ll-2-i, preferably in a total amount of 2.5% by weight or more, more preferably 3.5% by weight or more and in particular 4.5% by weight or more, and/or
- one or more compounds of formula I V-1 preferably selected from CC-n-V and CC-n-Vm, more preferably from CC-n-V, and in particular CC-3-V, CC-3-V1 and/or CC-3-2V1 , preferably in a total amount of at least 10% by weight, more preferably at least 20% by weight, even more preferably at least 30% by weight and in particular at least 34% by weight, and/or
- one or more compounds of formula VI-1 preferably PP-n-2Vm and in particular PP-1 -2V1 , preferably in a total amount of at least 2.5% by weight, more preferably at least 4% by weight, and in particular at least 7.5% by weight, and/or
- alkyl or “alkyl*" herein encompasses straight-chain and branched alkyl groups, preferably having 1-6 carbon atoms, in particular the straight-chain groups methyl, ethyl, propyl, butyl, pentyl and hexyl. Groups having 2-5 carbon atoms are generally preferred. Branched alkyl groups may be selected from secondary and/or tertiary alkyl, preferably from secondary alkyl.
- alkenyl or “alkenyl*” encompasses straight-chain and branched alkenyl groups, preferably having 2-6 carbon atoms, in particular the straight-chain groups.
- Preferred alkenyl groups are C 2 -C 7 -1E-alkenyl, C 4 -C 6 -3E-alkenyl, in particular C 2 -C 6 -1E-alkenyl.
- alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl and 5-hexenyl.
- fluoroalkyl preferably encompasses straight-chain groups having a terminal fluorine, i.e.
- oxaalkyl or "alkoxy” preferably encompasses straight-chain radi- cals of the formula C n H 2 n+1-O-(CH 2 )m, in which n and m each, independently of one another, denote 1 to 6. m may also denote 0.
- liquid-crystal medium additionally comprises one or more polymerisable compounds.
- R° and R 00 each, independently of one another, denote H or alkyl having 1 to 12 C atoms, m denotes 0, 1 , 2, 3 or 4, n1 denotes 1 , 2, 3 or 4,
- Y 1 denotes halogen
- R x denotes P, P-Sp-, H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH 2 groups may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that 0 and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
- Particularly preferred compounds of the formula M are those in which B 1 and B 2 each, independently of one another, denote 1 ,4-phenylene, 1 ,3- phenylene, naphthalene-1 ,4-diyl, naphthalene-2,6-diyl, phenanthrene-2,7- diyl, 9,10-dihydro-phenanthrene-2,7-diyl, anthracene-2,7-diyl, fluorene-2,7- diyl, coumarine, flavone, where, in addition, one or more CH groups in these groups may be replaced by N, cyclohexane-1 ,4-diyl, in which, in addition, one or more non-adjacent CH 2 groups may be replaced by 0 and/or S, 1 ,4-cyclohexenylene, bicycle[1.1.1]pentane-1 ,3-diyl, bicyclo[2.2.2]octane-1
- Particularly preferred compounds of the formula M are those in which B 1 and B 2 each, independently of one another, denote 1 ,4-phenylene, 1 ,3- phenylene, naphthalene-1 ,4-diyl or naphthalene-2,6-diyl.
- Very preferred compounds of formula M are selected from the following formulae: in which the individual radicals, on each occurrence identically or differently, and each, independently of one another, have the following meaning:
- P 1 , P 2 , P 3 a polymerisable group, preferably selected from vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane and epoxy,
- R aa one or more of the radicals P 1 -Sp 1 -, P 1 -Sp 2 - and P 3 -Sp 3 - may denote R aa , with the proviso that at least one of the radicals P 1 -Sp 1 -, P 2 -Sp 2 and P 3 -Sp 3 - present is different from R aa , preferably -(CH 2 ) P I-, -(CH 2 ) P I-O-, -(CH 2 ) P I-CO-O- or - (CH 2 ) P I-O-CO-O-, in which p1 is an integer from 1 to 12,
- R aa H, F, Cl, CN or straight-chain or branched alkyl having 1 to
- Rv and R z H, F, CH 3 or CF 3 , X 1 , X 2 , X 3 -CO-O-, -O-CO- or a single bond,
- trireactive compounds M15 to M31 in particular M17, M18, M19, M22, M23, M24, M25, M30 and M31 .
- L on each occurrence identically or differently, has one of the meanings given above or below, and is preferably F, Cl, CN, NO2, CH 3 , C 2 H 5 , C(CH 3 ) 3 , CH(CH 3 ) 2, CH 2 CH(CH 3 )C 2 H 5 , OCH 3I OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3I OCHF 2 , OC2F5 or P-Sp-, very preferably F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 , OCF 3 or P-Sp-, more preferably F, Cl, CH 3 , OCH 3 , COCH 3 or OCF 3 , especially F or CH 3 .
- Preferred compounds of formulae M1 to M31 are those in which P 1 , P 2 and P 3 denote an acrylate, methacrylate, oxetane or epoxy group, very preferably an acrylate or methacrylate group.
- Further preferred compounds of formulae M1 to M31 are those in which one of Sp 1 , Sp 2 and Sp 3 is a single bond and another one of Sp 1 , Sp 2 and Sp 3 is different from a single bond.
- Further preferred compounds of formulae M1 to M31 are those in which those groups Sp 1 , Sp 2 and Sp 3 that are different from a single bond denote -(CH 2 )si-X"-, in which s1 is an integer from 1 to 6, preferably 2, 3, 4 or 5, and X" is X" is the linkage to the benzene ring and is -O-, -O-CO-, -CO-O- -O-CO-O- or a single bond.
- liquid-crystalline media comprising one, two or three polymerisable compounds of formula M, preferably selected from formulae M1 to M31.
- liquid-crystalline media according to the present invention comprise one or more polymerisable compounds selected from Table G below.
- the proportion of polymerisable compounds in the liquidcrystalline medium is from 0.01 to 5%, very preferably from 0.05 to 1 %, most preferably from 0.1 to 0.5%.
- liquid-crystalline medium is especially suitable for use in PSA displays where it shows low image sticking, a quick and complete polymerisation, the quick generation of a low pretilt angle which is stable after UV exposure, a high reliability, high VHR value after UV exposure, and a high birefringence.
- polymerisable compounds it is possible to increase the absorption of the liquid-crystalline medium at longer UV wavelengths, so that it is possible to use such longer UV wavelengths for polymerisation, which is advantageous for the display manufacturing process.
- the polymerisable group P is a group which is suitable for a polymerisation reaction, such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain.
- a polymerisation reaction such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain.
- groups which are suitable for polymerisation with ring opening such as, for example, oxetane or epoxide groups.
- Sp is different from a single bond, it is preferably of the formula Sp"-X", so that the respective radical P-Sp- conforms to the formula P-Sp"-X"-, in which Sp" denotes alkylene having 1 to 20, preferably 1 to 12, C atoms, which is optionally mono- or polysubstituted by F, Cl, Br, I or CN and in which, in addition, one or more non-adjacent CH 2 groups may each be replaced, independently of one another, by -O-, -S-, -NH-, -N(R 0 )-, -Si(R 0 R 00 )-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -S-CO-, -CO-S-, -N(R 00 )-CO-O-, -O-CO-N(R 0 )-, -N(R 0 )-CO-N(R 00
- X" is preferably -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR 0 -, -NR 0 - CO-, -NR 0 -CO-NR 00 - or a single bond.
- Typical spacer groups Sp and -Sp"-X"- are, for example, -(CH 2 )p1-, - (CH 2 CH 2 O) q1 -CH 2 CH 2 -, -CH 2 CH 2 -S-CH 2 CH 2 -, -CH 2 CH 2 -NH-CH 2 CH 2 - or - (SiR 0 R 00 -O) p1 -, in which p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and R 0 and R 00 have the meanings indicated above.
- Particularly preferred groups Sp and -Sp”-X”- are -(CH 2 ) p1 -, -(CH 2 ) p1 -O-, -(CH 2 ) p1 -O-CO-, -(CH 2 ) p1 -CO-O-, -(CH 2 ) p1 -O-CO-O-, in which p1 and q1 have the meanings indicated above.
- Particularly preferred groups Sp" are, in each case straight-chain, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene-N-methylimino- ethylene, 1-methylalkylene, ethenylene, propenylene and butenylene.
- the polymerisable compounds contained in the liquid-crystalline medium are polymerised or crosslinked (if one compound contains two or more polymerisable groups) by in-situ polymerisation in the liquid-crystalline medium between the substrates of the LC display, optionally while a voltage is applied to the electrodes.
- the structure of the PSA displays according to the invention corresponds to the usual geometry for PSA displays, as described in the prior art cited at the outset. Geometries without protrusions are preferred, in particular those in which, in addition, the electrode on the colour filter side is unstructured and only the electrode on the TFT side has slots. Particularly suitable and preferred electrode structures for PS-VA displays are described, for example, in US 2006/0066793 A1.
- liquid-crystalline media containing polymerisable compounds allows the rapid establishment of a particularly low pretilt angle in PSA displays.
- the liquid-crystalline media exhibit significantly shortened response times, in particular also the grey-shade response times, in PSA displays compared with the media from the prior art.
- liquid-crystalline media which have a nematic liquid-crystalline phase, and preferably have no chiral liquid crystal phase.
- the invention also relates to the use of a liquid-crystalline medium according to the present invention as described above and below for electro-optical purposes, in particular for the use is in shutter glasses, for 3D applications, in TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB- FFS, PS-FFS, positive VA and positive PS-VA displays, and to electro- optical displays, in particular of the aforementioned types, containing a liquid-crystalline medium according to the present invention as described above and below, in particular a TN, PS-TN, STN, TN-TFT, OCB, IPS, PS- IPS, FFS, HB-FFS, PS-FFS, positive VA (vertically aligned) or positive PS- VA display.
- the invention also relates to electro-optical displays, such as, for example, STN or MLC displays, having two plane-parallel outer plates, which, together with a frame, form a cell, integrated non-linear elements for switching individual pixels on the outer plates, and a nematic liquid-crystal mixture having positive dielectric anisotropy and high specific resistance located in the cell, wherein the a nematic liquid-crystal mixture is a liquid-crystalline medium according to the present invention as described above and below.
- electro-optical displays such as, for example, STN or MLC displays, having two plane-parallel outer plates, which, together with a frame, form a cell, integrated non-linear elements for switching individual pixels on the outer plates, and a nematic liquid-crystal mixture having positive dielectric anisotropy and high specific resistance located in the cell, wherein the a nematic liquid-crystal mixture is a liquid-crystalline medium according to the present invention as described above and below.
- the liquid-crystalline media according to the invention enable a significant broadening of the available parameter latitude.
- the achievable combinations of clearing point, viscosity at low temperature, thermal and UV stability and suitable optical anisotropy are superior to previous materials from the prior art.
- Comparative measurements of the voltage holding ratio (VHR) are shown e.g. in S. Matsumoto et al., Liquid Crystals 5, 1320 (1989); K. Niwa et al., Proc. SID Conference, San Francisco, June 1984, p. 304 (1984); G. Weber et al., Liquid Crystals 5, 1381 (1989).
- the construction of the MLC display according to the invention from polaris- ers, electrode base plates and surface-treated electrodes corresponds to the usual design for displays of this type.
- the term usual design is broadly drawn here and also encompasses all derivatives and modifications of the MLC display, in particular including matrix display elements based on poly-Si TFTs or MIM.
- liquid-crystalline media which can be used in accordance with the invention are prepared in a manner conventional per se, for example by mixing the compound(s) as set forth in claim 1 with further mesogenic compounds and/or additives.
- the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
- the liquid-crystalline media may also comprise further additives known to the person skilled in the art and described in the literature, such as, for example, polymerisation initiators, inhibitors, surface-active substances, stabilizers, antioxidants, e.g. BHT, TEMPOL, microparticles, free-radical scavengers, nanoparticles, etc.
- further additives known to the person skilled in the art and described in the literature, such as, for example, polymerisation initiators, inhibitors, surface-active substances, stabilizers, antioxidants, e.g. BHT, TEMPOL, microparticles, free-radical scavengers, nanoparticles, etc.
- BHT stabilizers
- antioxidants e.g. BHT, TEMPOL
- microparticles e.g. BHT, TEMPOL
- microparticles e.g. TEMPOL
- free-radical scavengers e.g. TEMPOL
- nanoparticles
- the liquid-crystalline media contain one or more chiral dopants, preferably in a concentration from 0.01 to 1% by weight, very preferably from 0.05 to 0.5% by weight.
- the chiral dopants are preferably selected from the group consisting of compounds from Table E below, very preferably from the group consisting of R- or S-1011 , R- or S-2011 , R- or S- 3011 , R- or S-4011 , and R- or S-5011 .
- liquid-crystalline media contain a racemate of one or more chiral dopants, which are preferably selected from the chiral dopants mentioned in the previous paragraph.
- the LC medium according to the present invention contains a self-aligning (SA) additive, preferably in a concentration of 0.1 to 2.5% by weight.
- SA self-aligning
- An LC medium according to this embodiment is especially suitable for use in polymer stabilised SA-FFS or SA-HB-FFS displays.
- the SA-FFS or SA-HB-FFS display according to the present invention does not contain a polyimide alignment layer. In another preferred embodiment the SA-FFS or SA-HB-FFS display contains a polyimide alignment layer.
- Preferred SA additives for use in this embodiment are selected from compounds comprising a mesogenic group and a straight-chain or branched alkyl side chain that is terminated with one or more polar anchor groups selected from hydroxy, carboxy, amino or thiol groups.
- SA additives contain one or more polymerisable groups which are attached, optionally via spacer groups, to the mesogenic group.
- These polymerisable SA additives can be polymerised in the LC medium under similar conditions as applied for the RMs in the PSA process.
- Suitable SA additives to induce homeotropic alignment are described for example in US 2013/0182202 A1 , US 2014/0838581 A1 , US 2015/0166890 A1 and US 2015/0252265 A1 .
- an LC medium or a polymer stabilised SA- FFS or SA-HB-FFS display according to the present invention contains one or more self-aligning additives selected from Table H below.
- liquid-crystalline media for example, 0 to 15% by weight of pleochroic dyes, furthermore nanoparticles, conductive salts, preferably ethyldimethyldodecylammonium 4- hexoxybenzoate, tetrabutylammonium tetraphenylborate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst. 24, 249-258 (1973)), for improving the conductivity, or substances for modifying the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38281 , 24 50 088, 26 37 430 and 28 53 728.
- the displays according to the present invention are preferably addressed by an active matrix, preferably by a matrix of TFT.
- the liquid crystals according to the invention can also advantageously be used in displays having other known addressing means.
- n H 2n+1 , C m H 2m+1 and C1H21+1 or C n H 2n .-i, C m H 2m .-i and C1H21-1 denote straight-chain alkyl or alkenyl, preferably 1 E-alkenyl, having n, m and I C atoms respectively, where n, m and I, independently of one another, denote an integer from 1 to 9, preferably 1 to 7, or from 2 to 9, preferably 2 to 7, respectively.
- C O H 2O +I denotes straight-chain alkyl having 1 to 7, preferably 1 to 4, C atoms, or branched alkyl having 1 to 7, preferably 1 to 4, C atoms.
- Table A lists the codes used for the ring elements of the core structures of the compounds, while Table B shows the linking groups.
- Table C gives the meanings of the codes for the left-hand or right-hand end groups.
- Table D shows illustrative structures of compounds with their respective abbreviations.
- n and m each denote integers, and the three dots "...” are placeholders for other abbreviations from this table.
- Table D Illustrative structures The illustrative structures show compounds which are particularly preferably employed.
- k, I, m and n are, independently of one another, each an integer, preferably from 1 to 9, more preferably from 1 to 7.
- Table E indicates possible chiral dopants which are optionally added to the liquid-crystal media according to the invention.
- the liquid-crystal media preferably comprise 0-10% by weight, in particular 0.01-5% by weight and particularly preferably 0.01-3% by weight of chiral dopants.
- Stabilizers which may preferably be added to the liquid-crystal media in amounts of 0.005-3% by weight are shown below.
- n 1 , 2, 3, 4, 5, 6 or 7
- Table G shows illustrative reactive mesogenic compounds (RMs) which can be used in the liquid-crystal media in accordance with the present invention.
- RMs reactive mesogenic compounds
- the liquid-crystalline media according to the invention comprise one or more polymerisable compounds, preferably selected from the polymerisable compounds of the formulae RM-1 to RM-143.
- polymerisable compounds preferably selected from the polymerisable compounds of the formulae RM-1 to RM-143.
- compounds RM-1 , RM-4, RM-8, RM-17, RM-19, RM-35, RM-37, RM-39, RM-40, RM-41 , RM-48, RM-52, RM-54, RM-57, RM-64, RM-74, RM-76, RM-88, RM-102, RM-103, RM-109, RM-117, RM-120, RM-121 and RM-122 are particularly preferred.
- Table H shows self-alignment additives for vertical alignment which can be used in LC media for SA-VA and SA-FFS displays according to the present invention, optionally together with the polymerisable compounds, more preferably with the polymerisable compounds of formula M.
- the LC media and SA-FFS and SA-HB-FFS displays according to the present invention comprise one or more SA additives selected from formulae SA-1 to SA-34, preferably from formulae SA-14 to SA-34, more preferably from formulae SA-20 to SA-28, most preferably of formula SA-20, in particular in combination with one or more RMs of formula M.
- parts or per cent data denote parts by weight or per cent by weight based on the mixture as a whole.
- T(N,I) clearing point [°C]
- K33 elastic constant, "bend” deformation at 20°C [pN] LTS low-temperature stability of the phase, determined in bulk, and VHR voltage holding ratio.
- the term "threshold voltage” for the present invention relates to the capacitive threshold (V 0 ), unless explicitly indicated otherwise.
- the optical threshold can also be indicated, for example for 10% relative contrast (V10).
- Mixture M-1 CCP-V2-1 11.0% CPGP-5-2 1.5% PP-1-2V1 4.5% compound II-1-g 18.0% compound I-A 10.0% ⁇ 100.0% Mixture M-6 compound II-2-C 4.5% CC-3-V 28.0% CC-3-V1 6.0% CCP-3-3 5.5% CCP-V-1 11.0% CCP-V2-1 11.0% CPGP-5-2 1.5% PP-1-2V1 4.5% PUQU-3-F 18.0% compound I-B 10.0% ⁇ 100.0% Mixtures M-7, M-8 and M-9 Mixtures M-7, M-8 and M-9 are respectively prepared by mixing 99.7% of mixtures M-1, M-2 and respectively M-3 as described above with 0.3% of the compound of formula Compared to Comparative Mixture CM-1 , mixtures M-1 to M-9 give advantageously improved transmittance in displays.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La présente invention concerne des dérivés de 4,6-difluorodibenzothiophène de formules I-1 et I-2, un procédé pour leur préparation, des milieux de cristaux liquides (LC) comprenant ces dérivés et des dispositifs électro-optiques et en particulier des dispositifs d'affichage contenant ces milieux de cristaux liquides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20202543 | 2020-10-19 | ||
PCT/EP2021/078562 WO2022084168A1 (fr) | 2020-10-19 | 2021-10-15 | Dérivés de 4,6-difluorodibenzothiophène et milieu de cristaux liquides les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4229046A1 true EP4229046A1 (fr) | 2023-08-23 |
Family
ID=73005321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21790221.2A Pending EP4229046A1 (fr) | 2020-10-19 | 2021-10-15 | Dérivés de 4,6-difluorodibenzothiophène et milieu de cristaux liquides les contenant |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4229046A1 (fr) |
CN (1) | CN116368132A (fr) |
TW (1) | TW202222791A (fr) |
WO (1) | WO2022084168A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023209049A1 (fr) * | 2022-04-29 | 2023-11-02 | Merck Patent Gmbh | Milieu cristal liquide |
CN115612501A (zh) * | 2022-08-04 | 2023-01-17 | Tcl华星光电技术有限公司 | 液晶组合物、液晶介质和电光显示元件 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795849A (fr) | 1972-02-26 | 1973-08-23 | Merck Patent Gmbh | Phases nematiques modifiees |
US3814700A (en) | 1972-08-03 | 1974-06-04 | Ibm | Method for controllably varying the electrical properties of nematic liquids and dopants therefor |
DE2450088A1 (de) | 1974-10-22 | 1976-04-29 | Merck Patent Gmbh | Biphenylester |
DE2637430A1 (de) | 1976-08-20 | 1978-02-23 | Merck Patent Gmbh | Fluessigkristallines dielektrikum |
DE2853728A1 (de) | 1978-12-13 | 1980-07-17 | Merck Patent Gmbh | Fluessigkristalline carbonsaeureester, verfahren zu ihrer herstellung, diese enthaltende dielektrika und elektrooptisches anzeigeelement |
DE4042747B4 (de) | 1990-01-09 | 2009-10-08 | Merck Patent Gmbh | Elektrooptisches Flüssigkristallschaltelement |
JPH07181439A (ja) | 1993-12-24 | 1995-07-21 | Hitachi Ltd | アクティブマトリクス型液晶表示装置 |
JP3543351B2 (ja) | 1994-02-14 | 2004-07-14 | 株式会社日立製作所 | アクティブマトリクス型液晶表示装置 |
TW262553B (fr) | 1994-03-17 | 1995-11-11 | Hitachi Seisakusyo Kk | |
DE19528106A1 (de) | 1995-02-03 | 1996-08-08 | Merck Patent Gmbh | Elektrooptische Flüssigkristallanzeige |
DE19528107B4 (de) | 1995-03-17 | 2010-01-21 | Merck Patent Gmbh | Flüssigkristallines Medium und seine Verwendung in einer elektrooptischen Flüssigkristallanzeige |
EP0807153B1 (fr) | 1995-02-03 | 2001-03-28 | MERCK PATENT GmbH | Affichage electro-optique a cristaux liquides |
DE19509410A1 (de) | 1995-03-15 | 1996-09-19 | Merck Patent Gmbh | Elektrooptische Flüssigkristallanzeige |
DE10101022A1 (de) | 2001-01-11 | 2002-07-18 | Clariant Internat Ltd Muttenz | Fluorierte Aromaten und ihre Verwendung in Flüssigkristallmischungen |
JP4387276B2 (ja) | 2004-09-24 | 2009-12-16 | シャープ株式会社 | 液晶表示装置 |
DE102011108708A1 (de) | 2010-09-25 | 2012-03-29 | Merck Patent Gmbh | Flüssigkristallanzeigen und flüssigkristalline Medien mit homöotroper Ausrichtung |
US9674945B2 (en) | 2012-09-21 | 2017-06-06 | Intel Corporation | Heterogeneous integration of microfluidic devices in package structures |
KR20150070027A (ko) | 2013-12-16 | 2015-06-24 | 메르크 파텐트 게엠베하 | 액정 매질 |
EP2918658B1 (fr) | 2014-03-10 | 2020-05-13 | Merck Patent GmbH | Milieux cristallins liquides présentant une disposition homéotrope |
EP2937342B1 (fr) | 2014-04-22 | 2016-11-30 | Merck Patent GmbH | Dérivés de 4,6-difluoro-dibenzothiophène |
-
2021
- 2021-10-15 CN CN202180071095.4A patent/CN116368132A/zh active Pending
- 2021-10-15 EP EP21790221.2A patent/EP4229046A1/fr active Pending
- 2021-10-15 WO PCT/EP2021/078562 patent/WO2022084168A1/fr unknown
- 2021-10-18 TW TW110138478A patent/TW202222791A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022084168A1 (fr) | 2022-04-28 |
CN116368132A (zh) | 2023-06-30 |
TW202222791A (zh) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101675175B1 (ko) | 티오펜 유도체 및 이를 함유하는 액정 매질 | |
JP7372827B2 (ja) | 液晶媒体 | |
TWI651399B (zh) | 液晶介質 | |
KR101636590B1 (ko) | 액정 매질 | |
KR101592052B1 (ko) | 티오펜 유도체 및 이를 함유하는 lc 매질 | |
JP7274185B2 (ja) | 液晶媒体 | |
KR101868648B1 (ko) | 티오펜 유도체를 함유하는 액정 매질 | |
CN101302145A (zh) | 茋衍生物、液晶混合物和电光显示器 | |
EP3870671B1 (fr) | Milieu liquide cristallin | |
KR101676034B1 (ko) | 액정 화합물 및 액정 매질 | |
EP3985085B1 (fr) | Support à cristaux liquides | |
EP4229046A1 (fr) | Dérivés de 4,6-difluorodibenzothiophène et milieu de cristaux liquides les contenant | |
KR101780517B1 (ko) | 액정 매질 | |
WO2022096483A1 (fr) | Milieu à cristaux liquides comprenant des composés polymérisables | |
EP4022009A1 (fr) | Milieu à cristaux liquides | |
EP3757192A1 (fr) | Matière à base de cristaux liquides | |
WO2023198671A1 (fr) | Milieu cristallin liquide | |
WO2022106387A1 (fr) | Milieu à cristaux liquides | |
EP4306614A1 (fr) | Milieu à base de cristaux liquides | |
KR20230137251A (ko) | 액정 매질 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230417 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |